$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Optical biomedical imaging has been pivotal in advancing our understanding of biological structure and function. The images are generated by modulating excitation light and detecting signals from light-tissue interactions. The first compound microscope, developed by Hans and Zacharias Janssen around 1590, utilized two convex lenses in a tube, providing magnification up to 30x1. Modern optical microscopes, following centuries of advancements, can now achieve resolutions as fine as 1-3 nm2,3. In addition to offering high resolution, advanced imaging systems now provide deeper tissue penetration, greater efficiency, and minimal sample damage, making them especially suited for live cell and tissue imaging. Label-free imaging is particularly advantageous as it captures information without disrupting intracellular processes or compromising sample integrity.
Multiphoton fluorescence (MPF) microscopy, particularly two-photon fluorescence microscopy, has been extensively used for label-free imaging. Unlike conventional fluorescence microscopy, which relies on linear single-photon absorption and emission, MPF excitation involves the simultaneous absorption of multiple photons, whose combined energy excites a single fluorophore molecule4,5. These photons, typically in the infrared spectrum, possess half or less of the energy required for single-photon excitation. The longer wavelengths and localized excitation at the focal point in this nonlinear process result in lower scattering, deeper tissue penetration, and reduced phototoxicity.
Cellular metabolic information can be captured by label-free MPF microscopy through the detection of autofluorescence signals from endogenous metabolic substrates, such as reduced nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD). These coenzymes exhibit distinct excitation and emission spectra, and their fluorescence intensity ratio, known as the redox ratio (NADH/FAD), reflects the cell's oxidative state. Since Britton Chance first introduced the concept of the redox ratio in 1979, additional ratios, including NAD(P)H/FAD, NAD(P)H/(FAD + NAD(P)H), and FAD/(FAD + NAD(P)H), have been proposed6,7,8,9. Quantifying these optical redox ratios via MPF imaging provides valuable insight into metabolic dynamics. For instance, MPF imaging can distinguish cancer cells from normal cells based on their altered metabolism, demonstrating its potential for cancer diagnosis10,11,12. However, MPF-based autofluorescence detection has limitations. Other intrinsic fluorophores, such as keratin, may contribute to fluorescence intensity, leading to spectral crosstalk and inaccurate signal interpretation13. Additionally, the redox ratio only reflects overall cellular oxidation-reduction changes and does not distinguish between NADH from different sources (e.g., cytoplasmic or mitochondrial) or between NADH and NAD(P)H, as both exhibit similar spectral peaks at 450 nm, resulting in blended intensity signals14.
Second Harmonic Generation (SHG), a nonlinear optical process first demonstrated in the biomedical field in the 1980s, has been widely utilized for label-free imaging of cellular structures15,16. Similar to MPF, SHG involves the simultaneous absorption of two photons of the same energy from an ultrafast pulsed laser. These photons are recombined to emit a new photon twice the frequency of the incident light, resulting in the detection of the second-harmonic signal. This non-linear optical interaction occurs exclusively in non-centrosymmetric materials that exhibit a non-zero second-order susceptibility to induce a polarization for generating the second harmonic signal17,18. This makes SHG particularly effective for imaging the filamentous proteins and fibrillar structures, such as collagen, myosin, and tubulin, without requiring exogenous fluorescence dyes15,17,19,20. The abnormality in abundance, stiffness, alignment, and structure of fibrosis and collagen are prevalent in many conditions such as inflammation and cancer, making SHG a promising tool for efficient and non-invasive detection for certain disease conditions21,22,23. The widespread application of SHG imaging in oncological research, including studies on breast, ovarian, and skin cancers, has highlighted its crucial role in both fundamental research and potential clinical applications24,25,26,27.
Different molecules exhibit distinct vibrational energy levels, which induce varying degrees of inelastic scattering when excited by incident light-a phenomenon first characterized by C. V. Raman in 192828. The Raman effect has since been extensively utilized in optical microscopy for the detection of molecular and tissue compositions without exogenous labeling. Both Stimulated Raman Scattering (SRS) and coherent anti-Stokes Raman Scattering (CARS) excite molecular vibrations coherently and leverage the nonlinear interaction of light to produce a stronger signal compared to conventional Spontaneous Raman Spectroscopy. The SRS phenomenon was first reported in 196229. In 2008, this mechanism was integrated into three-dimensional multiphoton imaging, allowing for selective detection of chemicals based on intensity changes in the Pump and Stokes beams due to molecular vibrational transitions30. This method minimizes non-resonant background interference, generating a clean intensity signal that surpasses that of CARS. SRS imaging excels in providing multiplexed and hyperspectral imaging, enabling simultaneous detection of multiple chemical bonds and allowing high-resolution visualization of molecular composition in specimens with considerable penetration depth. Although a relatively new technique, SRS imaging has proven effective in both clinical diagnostics and metabolic research, in vivo and in vitro30,31,32,33,34,35,36. For example, SRS can differentiate brain tumor-infiltrated tissues from the cortex and white matter by quantifying the lipid-to-protein ratio, enabling the delineation of tumor margins in a label-free, non-invasive manner37,38. Additionally, metabolic alterations, often considered hallmarks of aging-related and cancer-associated diseases, can be quantitatively assessed using SRS achieved by detecting carbon-deuterium bonds in samples treated with heavy water (D2O), allowing quantitative measurement of protein synthesis, lipogenesis, and other macromolecular metabolic processes31,33,34,35,36. The ability to track metabolites with high temporal and spatial resolution positions SRS as a promising tool for disease investigation and diagnosis, with potential for broader clinical applications.
Multimodal imaging has emerged as a powerful approach in biomedical research, integrating two or more imaging modalities to gain a more comprehensive understanding of complex biological systems within the same specimen. In 2018, a label-free autofluorescence-multiharmonic (SLAM) microscopy technique was introduced, integrating two-photon fluorescence (2PF), three-photon fluorescence (3PF), SHG, and third harmonic generation (THG)39. This approach facilitates the simultaneous visualization of cellular interactions, dynamic processes, and individual components within the tumor microenvironment. SLAM microscopy offers minimal perturbation and reduced laser power requirements for the sample, enabling deep tissue profiling and providing a safer method for intravital monitoring40. Another multimodal modality, combining intrinsic fluorescence spectroscopy, diffuse reflectance spectroscopy, and Raman spectroscopy, has been developed for in situ cancer detection during surgical procedures41. Additionally, a recently designed multimodal non-linear endoscopy system, which integrates CARS, SHG, and two-photon fluorescence (TPF), has demonstrated the capability to image biological samples at sub-micron and sub-cellular spatial resolution42. Combined 2PF and SRS microscopy has similarly been utilized for high-resolution, in-vivo imaging of tissues, cells, and organelles42,43,44,45. These emerging multimodal imaging techniques harness the strengths of individual modalities, leading to improved resolution, penetration depth, and image acquisition efficiency, thus showing considerable potential for clinical and surgical applications.
This multi-modality approach is increasingly favored over single-modality imaging because it provides a broader range of measurements while mitigating the limitations associated with individual techniques. As previously discussed, MPF measures endogenous fluorescence to reflect metabolic changes, SHG can image non-centrosymmetric structures such as collagen in biological samples, and SRS predominantly detects proteins and lipids due to the high density of chemical bonds that generate distinctive Raman signals based on their vibrational modes. Given their coherent properties and the shared principle of nonlinear optical properties, these imaging modalities can be integrated into a single microscope setup utilizing ultrashort pulsed lasers, allowing for the acquisition of various biomarkers at localized regions to provide a more complete view of biological processes44,45. This paper outlines a protocol for implementing a multimodal imaging platform that integrates MPF, SHG, and SRS for biomedical research applications.